Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1995
08/15/1995US5441703 Having conicoidal interior contour which homogeneously widens flow of reactant gases
08/15/1995CA2142394A1 Organic compounds
08/15/1995CA1336711C Lactam derivatives, their preparation and their use as hypotensive agents
08/15/1995CA1336691C Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects
08/15/1995CA1336683C Diagnosis and treatment of double-stranded rna deficiency states
08/15/1995CA1336680C Method and compositions for the treatment and prevention of septic shock
08/15/1995CA1336679C Remedy for hematopoietic tissue diseases comprising human monocytic macrophage colony stimulating factor as active ingredient
08/15/1995CA1336678C Prophylaxis and treatment of nervous system diseases with melanin
08/15/1995CA1336677C Compositions having use as treatment of psoriasis and neuropsychiatric deficits
08/15/1995CA1336676C Intravaginal delivery of biologically active polypeptides
08/11/1995CA2142173A1 Hirudin derivatives and a process for their preparation
08/10/1995WO1995021258A1 Fusion proteins that include antibody and nonantibody portions
08/10/1995WO1995021256A1 Msrv1 virus and msrv2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same
08/10/1995WO1995021254A1 Multivariant il-3 hematopoiesis fusion protein
08/10/1995WO1995021253A1 Ets1 gene: a human tumor suppressor gene
08/10/1995WO1995021251A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
08/10/1995WO1995021248A1 Method for using tobacco mosaic virus to overproduce peptides and proteins
08/10/1995WO1995021245A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
08/10/1995WO1995021197A1 Il-3 variant hematopoiesis fusion protein
08/10/1995WO1995021195A1 Non-viral vector
08/10/1995WO1995021194A1 Superactive vip antagonists
08/10/1995WO1995021193A1 Nerve growth factor structural analogs and their uses
08/10/1995WO1995021187A1 Cyclic neurokinin a antagonists
08/10/1995WO1995021186A1 Macrocyclic difluorostatone derivatives useful as antiviral agents
08/10/1995WO1995021184A1 Substituted purines and oligonucleotide cross-linking
08/10/1995WO1995021175A1 Pharmaceutically active compounds and liposomes, and methods of use therof
08/10/1995WO1995020980A1 Method for increasing bioavailability of oral pharmaceutical compositions
08/10/1995WO1995020979A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
08/10/1995WO1995020978A1 Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels
08/10/1995WO1995020977A1 Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production
08/10/1995WO1995020976A1 Co-administration of interleukin-3 mutants with colony stimulating factors
08/10/1995WO1995020975A1 Tef-1 isoforms and uses thereof
08/10/1995WO1995020974A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides
08/10/1995WO1995020973A1 Peptides and compounds that bind to the il-1 receptor
08/10/1995WO1995020972A1 Treatment of ovarian estrogen dependent conditions
08/10/1995WO1995020971A1 Therapeutic composition for replacing and/or supplementing body fluids
08/10/1995WO1995020959A1 Use of sialic acid or antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
08/10/1995WO1995020957A1 Process for making avermectin/zein compositions
08/10/1995WO1995018830A3 Inhibitors of human plasmin derived from the kunitz domains
08/10/1995WO1995016709A3 Anti-mullerian hormone receptor polypeptides and antibodies thereto
08/10/1995WO1995015373A3 Inhibition of dna methyltransferase
08/10/1995DE4435086C1 Conjugate for inducing cellular immunity contains CD8 positive cell epitope
08/10/1995DE4404002A1 New thiazolyl-peptide derivs.
08/10/1995DE4403665A1 Bovine and human endothelin converting enzymes and corresp. DNA
08/10/1995CA2182731A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
08/10/1995CA2182723A1 The use of anti-tnf antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6
08/10/1995CA2182685A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
08/10/1995CA2182616A1 Non-viral vector
08/10/1995CA2182498A1 Fusion proteins that include antibody and nonantibody portions
08/10/1995CA2182485A1 Pharmaceutically active compounds and liposomes, and methods of use thereof
08/10/1995CA2182484A1 Multivariant il-3 hematopoiesis fusion protein
08/10/1995CA2182474A1 Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production
08/10/1995CA2182473A1 Co-administration of interleukin-3 mutants with colony stimulating factors
08/10/1995CA2182369A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides
08/10/1995CA2177175A1 Method for increasing bioavailability of oral pharmaceutical compositions
08/10/1995CA2159217A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
08/09/1995EP0666315A1 Thrombocytestabilizing Factor-1X fragments, their preparation and use, and medicine containing them
08/09/1995EP0666313A2 Targeting of telomerase in cancer gene therapy
08/09/1995EP0666271A1 Type 1 and type P fimbriae-adhesins isolated from novel E. coli strains, process for their preparation and uses thereof
08/09/1995EP0666270A2 Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoprotein
08/09/1995EP0666080A1 Treatment of autoimmune diseases by oral administration of autoantigens
08/09/1995EP0666034A1 Process for preparing fractionated soybean proteins and foods using the same
08/09/1995EP0665888A1 Ryegrass pollen allergen
08/09/1995EP0665887A1 Human 5-ht 2? receptor
08/09/1995EP0665885A1 Polypeptides (5ht2c) having a serotoninergic receptor activity and uses thereof
08/09/1995EP0665853A1 Multimeric polyvalent antithrombotic agents
08/09/1995EP0665852A1 Recombinant ctla4 polypeptides and methods for making the same
08/09/1995EP0665850A1 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions
08/09/1995EP0665755A1 Preparation of pharmaceutical compositions containing a calcitonin
08/09/1995EP0665754A1 Antimicrobial peptides
08/09/1995EP0665747A1 Benzo-fused lactams promote release of growth hormone
08/09/1995EP0665746A1 CONTROLLED-pH FORMULATION FOR INTRAVESICULAR INSTILLATION OF TGF$g(a)PE 40?ab
08/09/1995EP0665739A1 Morphogen-induced periodontal tissue regeneration
08/09/1995EP0665721A1 Anti-diarrheic product and method of treating rotavirus-associated infection
08/09/1995EP0659179A4 Benzo-fused lactams promote release of growth hormone.
08/09/1995EP0463152B1 Method of inhibiting angiogenesis of tumors
08/09/1995EP0403631B1 Method of making high density solder bumps and a substrate socket for high density solder bumps
08/09/1995EP0365525B1 Lymphocyte inhibition by hla peptides
08/09/1995CN1106297A 复方免疫抗生素 Immune antibiotic compound
08/09/1995CN1106296A Nutritional Supplement
08/09/1995CN1106263A Complexes of anti-aids virus
08/09/1995CA2140379A1 Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus e7 oncoprotein
08/08/1995US5440021 A monoclonal antibody as antiinflammatory agent treating an inflammatory disorder
08/08/1995US5440020 Active segment which blocks interaction of fibrinogen with platelets to prevent thrombus formation
08/08/1995US5440019 Processes of producing amylase inhibitors
08/08/1995US5440018 Ultrfiltration, acidd treating, ion exchanging, purifying
08/08/1995US5440017 T-cell lymphoma cDNA clones
08/08/1995US5440015 Selectin peptide medicaments for treating disease
08/08/1995US5440014 Fibronectin binding peptide
08/08/1995US5440013 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
08/08/1995US5440012 Excellent blood calcium-decreasing activity and chondrocyte differentiating-promoting activity
08/08/1995US5439935 Topical application of mixtures containing a glucosidase and a protease, separately or together, for treatment of dry skin
08/08/1995US5439930 Biologically active n-acylprolydipeptides having antiamnestic, antihypoxic and anorexigenic effects
08/08/1995US5439918 Inhibitors of farnesyl-protein transferase
08/08/1995US5439888 Antithrombotic agents
08/08/1995US5439887 Peptide having antihypertensive activity free of vascoconstrictor activity
08/08/1995US5439886 Monoclonal antibody, polypeptides and production thereof
08/08/1995US5439885 CRF analogs
08/08/1995US5439884 Applying a polypeptide in vitro to stimulate the artificial insemination
08/08/1995US5439883 Mixture of cytochrome C, nicotinamide adenine dinucleotide and inosine to improve myocardial structure after injury or disease
1 ... 2834 2835 2836 2837 2838 2839 2840 2841 2842 2843 2844 2845 2846 2847 2848 2849 2850 2851 2852 2853 2854 ... 3163